
Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets
05/09/25 • 52 min
In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies.
Overseeing product launches in over 100 countries, he discusses the deep need for pain relief and other benefits of neuromodulation, and the challenges presented by EMEA’s unique health care markets.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to register. Use the discount code mentioned in the episode.
But we’ll start off the episode with MassDevice Editor Chris Newmarker’s #NewmarkersNewsmakers including Cardinal Health, AdvaMed, Zimmer Biomet, EndoGenex, HistoSonics, and orthopedic companies.
Go to MassDevice.com for our medical device coverage.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies.
Overseeing product launches in over 100 countries, he discusses the deep need for pain relief and other benefits of neuromodulation, and the challenges presented by EMEA’s unique health care markets.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to register. Use the discount code mentioned in the episode.
But we’ll start off the episode with MassDevice Editor Chris Newmarker’s #NewmarkersNewsmakers including Cardinal Health, AdvaMed, Zimmer Biomet, EndoGenex, HistoSonics, and orthopedic companies.
Go to MassDevice.com for our medical device coverage.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
Previous Episode

DeviceTalks Boston 2025 Wrap Up - We talk AI, CEO, Being Seen, and how we must make MedTech sexy
In this episode of the DeviceTalks Weekly Podcast, we review a few of the highlights of this week’s DeviceTalks Boston conference, a rip-roaring successful event! DeviceTalks Tom Salemi and Kayleen Brown sit down with MassDevice Editor Chris Newmarker and Joe Mullings of The Mullings Group to review a few of the sessions.
But the conversation took a turn into the personal, centering around how to use tools - including language, social media and networks - to tell stories and maintain connections.
Finally, the group unpacks discussion with Ivan Tornos, CEO of Zimmer Biomet, the Women in MedTech Breakfast, and what we can do to make MedTech more attractive to the next generation.
If you attended DeviceTalks Boston please fill out the feedback survey sent out on Friday! Help us make next year’s event even better.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
Next Episode

How ArteDrone hopes to democratize stroke treatment with digital maps and magnetic-driven devices
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi learns how ArteDrone, hopes to empower more interventionalists to deliver life-saving, stroke-clearing treatments. The company is combining digital twin navigation with a magnet-powered catheter to make clot removal more of a trade than an art. CEO Liane Teplitsky returns to DeviceTalks Weekly in her new role as CEO of the early-stage, VC-backed startup.
This episode is sponsored by DeviceTalks Minnesota. To review the agenda, go to Minnesota.DeviceTalks.com.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/devicetalks-podcast-network-310096/why-neuromodulation-devices-face-great-promise-and-challenges-for-grow-90942217"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to why neuromodulation devices face great promise – and challenges – for growth in emea markets on goodpods" style="width: 225px" /> </a>
Copy